SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 183 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $345,899,000 | -41.9% | 158,669 | 0.0% | 0.00% | – |
| Q2 2021 | $595,009,000 | -3.4% | 158,669 | -16.0% | 0.00% | – |
| Q1 2021 | $615,932,000 | +22.0% | 188,936 | +27.6% | 0.00% | – |
| Q4 2020 | $504,926,000 | +6.0% | 148,072 | +26.8% | 0.00% | – |
| Q3 2020 | $476,414,000 | +54.1% | 116,768 | +27.6% | 0.00% | – |
| Q2 2020 | $309,243,000 | +60.4% | 91,492 | +10.6% | 0.00% | – |
| Q1 2020 | $192,789,000 | -35.2% | 82,742 | +1.2% | 0.00% | – |
| Q4 2019 | $297,709,000 | -48.1% | 81,788 | +18.3% | 0.00% | – |
| Q3 2019 | $573,501,000 | +20.7% | 69,138 | +25.3% | 0.00% | – |
| Q2 2019 | $475,228,000 | -16.9% | 55,195 | +3.2% | 0.00% | – |
| Q1 2019 | $571,551,000 | +41.4% | 53,466 | +15.7% | 0.00% | – |
| Q4 2018 | $404,329,000 | -59.5% | 46,209 | -22.2% | 0.00% | -100.0% |
| Q3 2018 | $997,332,000 | -19.8% | 59,365 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,244,290,000 | +29.3% | 59,365 | -0.7% | 0.00% | 0.0% |
| Q1 2018 | $962,102,000 | -9.5% | 59,795 | +6.6% | 0.00% | 0.0% |
| Q4 2017 | $1,062,679,000 | +87.3% | 56,078 | +39.0% | 0.00% | 0.0% |
| Q3 2017 | $567,471,000 | +92.5% | 40,332 | +1.9% | 0.00% | – |
| Q2 2017 | $294,849,000 | +93.9% | 39,577 | +69.1% | 0.00% | – |
| Q1 2017 | $152,087,000 | +146137.5% | 23,398 | 0.0% | 0.00% | – |
| Q4 2016 | $104,000 | -53.6% | 23,398 | -51.2% | 0.00% | – |
| Q3 2016 | $224,000 | -28.9% | 47,898 | 0.0% | 0.00% | – |
| Q2 2016 | $315,000 | +3.3% | 47,898 | 0.0% | 0.00% | – |
| Q1 2016 | $305,000 | +5.2% | 47,898 | -0.4% | 0.00% | – |
| Q4 2015 | $290,000 | +34.9% | 48,072 | +33.6% | 0.00% | – |
| Q3 2015 | $215,000 | -12.6% | 35,972 | 0.0% | 0.00% | – |
| Q2 2015 | $246,000 | +17.7% | 35,972 | +4.7% | 0.00% | – |
| Q1 2015 | $209,000 | -5.4% | 34,372 | +7.8% | 0.00% | – |
| Q4 2014 | $221,000 | -14.7% | 31,872 | 0.0% | 0.00% | – |
| Q3 2014 | $259,000 | 0.0% | 31,872 | 0.0% | 0.00% | – |
| Q2 2014 | $259,000 | +3.6% | 31,872 | 0.0% | 0.00% | – |
| Q1 2014 | $250,000 | -0.8% | 31,872 | +11.9% | 0.00% | – |
| Q4 2013 | $252,000 | -6.3% | 28,472 | -11.2% | 0.00% | – |
| Q3 2013 | $269,000 | +12.6% | 32,072 | 0.0% | 0.00% | – |
| Q2 2013 | $239,000 | – | 32,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |